Skip to main content
PLOS One logoLink to PLOS One
. 2025 Sep 8;20(9):e0306677. doi: 10.1371/journal.pone.0306677

The association between limiting longstanding illness and serious psychological distress in adolescents: A secondary analysis of the UK Millennium Cohort Study

Gareth Martyn Palliser 1, Lorna K Fraser 2, Kate E Mooney 1,3, Stuart W Jarvis 1,*
Editor: Shivanand Kattimani4
PMCID: PMC12416657  PMID: 40920771

Abstract

Background

Previous studies have shown associations between specific limiting longstanding illnesses and mental health difficulties using cross-sectional studies in the UK. This study explored the association between having any limiting longstanding illness and serious psychological distress or of currently receiving treatment for depression or serious anxiety at age 17 years.

Methods

A secondary analysis of the UK Millennium Cohort Study was conducted. Outcome measures were dichotomised responses from the self-administered Kessler-6 questionnaire for nonspecific psychological distress, and self-reported current treatment for depression or serious anxiety. Limiting longstanding illness data and covariates were taken from questionnaires with parents and adolescents, from birth up to age 17 years. Data were analysed using multiple binary logistic regression, first using complete-case analysis, and then using multiple imputation using chained equations.

Results

Adolescents with a history of limiting longstanding illness were at an increased odds of both serious psychological distress (odds ratio = 1.53, 95%CI = 1.27–1.86) and self-reporting currently receiving treatment for depression or serious anxiety at age 17 years (odds ratio = 3.02, 95%CI 2.24–4.07).

Conclusion

Children and young people with a limiting longstanding illness are at increased risk of having serious psychological distress, depression, and serious anxiety. Practitioners should be aware of this and routine screening for psychological distress, plus additional preventative support, may be beneficial.

Introduction

Adolescence marks the period between childhood and adulthood, representing a key period in both physical and psychological development. National UK survey data found a prevalence of probable mental illness of 17.6% in those aged 6–16 years old in England [1], compared with 16.7% in adults in similar surveys [2]. Recently, mental health disorders for children and adolescents have become a public health crisis in England. Child referrals to mental health services more than doubled between 2020 and 2021 [3], and one in every five children aged 8–16 years old now experiences a mental health disorder [4]. A previous analysis of US national survey data [5] found that half of lifetime mental health disorders in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) [6] start by 14 years of age, and three-quarters occur by 24 years. Adolescent mental illness is therefore a critical period for research. Mental illness experienced in adolescence is associated with significant potential harms including lower educational achievement [7], alcohol and substance misuse [8], social isolation [9], and suicide and self-inflicted injury [10].

Longstanding illness is defined by The UK Department of Health [11] as any illness or condition which cannot be cured, but can instead be treated with pharmacological or other treatments; it is limiting if it reduces the ability of someone to take part in normal activities. As medical care improves, childhood mortality rates in those aged 1–15 years in England and Wales have decreased from 33 deaths per 100,000 in 1981–8 deaths per 100,000 in 2021 [12]. This, amongst other factors including a rise in sedentary lifestyles, has resulted in a global rise in the proportion of those surviving to live with a limiting longstanding illness (LLSI) in all age groups, including children and adolescents [13]. Adolescents with a limiting longstanding illness (LLSI) may face difficulties such as hospital appointments, disruptions to their routine and education, and reduced capability to take part in regular activities; these challenges could lead to mental health difficulties [14]. It is important to understand any association between physical and mental illnesses to inform prevention strategies and paediatric service delivery, and to understand whether the early provision of psychological support may be necessary for all children and adolescents with a chronic illness.

Previous cross-sectional and longitudinal studies have identified associations between LLSIs and mental health difficulties in children outside of the UK [1517]. Systematic reviews have identified that in adolescents, studies are largely constrained to identifying associations between diabetes or asthma and mental illness, with some evidence suggesting higher prevalence of mental health difficulties in those with inflammatory bowel disease, cystic fibrosis, and sickle cell disease [1820]. Further, few studies exploring longitudinal relationships between longstanding illnesses and mental health difficulties were at a low risk of methodological bias.

An analysis of a UK-based survey (n = 9,834) found that children and adolescents aged 5–15 years old with asthma were at a slightly increased odds of anxiety (OR=1.38, 95%CI 1.05–1.82) and hyperkinetic disorders (OR=1.64, 95%CI 1.00–2.39) when compared with those without asthma, measured using the Development and Well-Being Assessment [21]. Children with asthma who had parent-rated poor health were at significantly increased odds of scoring as borderline or abnormal for the parent (OR 3.1, 95%CI 2.4–4.1), teacher (OR 1.7, 95%CI 1.2–2.4), and child- (OR 1.9, 95%CI 1.2–3.0) rated total difficulties score on the Strengths and Difficulties Questionnaire, when compared with children without asthma who were in good health. Those with asthma but were in good health were not at a significantly increased odds of increased score on the Strengths and Difficulties Questionnaire, indicating that increased symptom severity in children with asthma may lead to increased risk of mental health difficulties.

One UK study (n = 14,775) using a secondary analysis of the Avon Longitudinal Study of Parents and Children found that those with a chronic illness had increased likelihood (OR 1.6, 95%CI 1.14–2.25) of having mental illness as measured by the Development and Well-Being Assessment at aged 15 years, compared with those without a chronic illness [22]. However, participants in this study were recruited from a single region in southwestern England, with those from disadvantaged or ethnic minority backgrounds being under-represented, and those from white ethnicity and advantaged backgrounds were over-represented.

As studies in adults have previously identified a bi-directional relationship between LLSI and mental health difficulties [23,24], this must be considered when interpreting estimates from cross-sectional studies. This study therefore explored the association between having any LLSI before aged 17 years with serious psychological distress at age 17 years in a large representative UK birth cohort- the Millennium Cohort Study. This study also investigated the relationship between LLSI and receiving treatment for depression or serious anxiety to explore not only any links between LLSI and psychological distress, but also associations with related healthcare use and to explore any differences between presence of psychological distress and access to related treatment.

Methods

Data source

This study uses a retrospective secondary analysis of data from the Millennium Cohort Study, a nationally representative UK birth cohort consisting of 19,517 cohort members and their families. Cohort members were recruited from the Child Benefit Register at age 9 months in data collection sweep 1 between the years 2000–2002, with some participants whose geographical data was unavailable recruited in sweep 2 at age 3 years [25]. A stratified sampling design was used, recruiting additional participants from areas with higher rates of minority ethnic groups and deprivation than the UK average. There are currently 7 sweeps of data; most recently when cohort members were aged 17 years [25]. Parents provided consent to take part in the study on behalf of cohort members up to age 11 years; from 14 years onwards, cohort members provided consent themselves.

Outcome measures

Cohort members completed the Kessler-self-administered 6-item questionnaire (K6) at age 17 years. The scale is designed to measure non-specific psychological distress, and is scored from 0–24, with a cut-point of ≥13 indicating serious distress used frequently throughout the literature [2628]. All participants with scores between 0–12 were coded as not having psychological distress, and participants with scores between 12–24 were considered as having serious psychological distress [28]. The K6 has an area under the receiver operating characteristic curve (AUROC) of 86.5%, compared with 85.4% in the 10-item version of the Kessler scale (K10), indicating the K6 performs slightly better than the K10 at distinguishing between those with and without serious mental illness [29]. The scale demonstrates high internal consistency, with Cronbach’s alpha estimates across varying languages, countries, and settings ranging from 0.81 to 0.89 in a single factor structure [2932].

At age 17, cohort members were asked ‘Has a doctor ever told you that you suffer from depression or serious anxiety?’. Where cohort members responded with ‘yes’ they were further asked ‘are you currently being treated for depression or serious anxiety?’. Those who answered ‘yes’ to both questions were counted as having the second outcome of current treatment for depression or serious anxiety. This enabled some exploration of contact with healthcare services and treatment.

Exposure

LLSI status was gathered on behalf of cohort members from parent/main carer interviews, between the ages of 3 and 14 years. The parent or main carer of each cohort member was asked ‘Does [cohort member] have a longstanding illness or condition?’ at each sweep; for those who answered ‘yes’ they were further asked ‘Does this illness limit [cohort member]’s activity in any way?. For the purposes of this study, respondents whose parent or main carer answered ‘yes’ to both questions at any sweep were considered to have an LLSI, and respondents whose parents answered no to both, or no to the second question were considered to not have an LLSI, and were used as the reference group. At age 11 and 14 years, participants who answered ‘yes’ were also asked which health conditions affect the cohort member; those who reported being affected exclusively by a mental health condition, and not by any other condition, were not considered to have an LLSI.

Covariates

All covariates were taken from face-to-face interviews with each cohort member’s parent or main carer, at age 9 months for those in the original sample, and age 3 years for those in the booster sample. Covariates selection for this study was informed by previous studies; all covariates, are theorised to confound the relationship between LLSI and serious psychological distress [3336] [see Fig 1]. Covariates were:

Fig 1. Directed acyclic graph of relationships between measured variables in this study.

Fig 1

Note: arrows between confounders have been removed to simplify the presentation of the DAG.

  • • cohort member sex (coded as 0 = male, 1 = female)

  • • ethnic group (coded as 0 = White British (reference group), 1 = Pakistani and Bangladeshi, 2 = Black or Black British, 3 = Mixed or Other Ethnic group)

  • • family structure (coded as 0 = dual-parent family, 1 = single-parent family)

  • • being above or below the 60% median on the Organisation for Economic Co-operation and Development equivalised income scale (coded as 0=above median, 1=below median)

  • • highest parental qualification, coded according to National Vocational Qualification (NVQ) or equivalent levels, i.e., (as 0 = none or overseas qualification, 1 = NVQ level 1 (lower grades at school qualifications typically gained at age 16), 2 = NVQ level 2 (higher grades at school qualification typically gained at age 16, 3 = NVQ level 3 (school qualifications typically gained at age 18), 4 = NVQ level 4 (further education or undergraduate degree level qualifications), 5 = NVQ level 5 (higher than degree – e.g., masters level/doctoral – qualifications)

  • • parental self-reported LLSI (coded as 0 = no LLSI, 1 = LLSI present)

  • • parental K6 score (continuous).

Statistical analyses

For the primary outcome of psychological distress measured by K6 score, complete-case analyses were used. Complete case analyses were also used for the secondary outcome of whether a cohort member reported currently receiving treatment for depression or serious anxiety. To minimise attrition, participants with LLSI data for at least one sweep were included, providing that all covariate data were available. Where there was more than one cohort member in a family, the second cohort member was excluded to prevent clustering by household. The MCS used a stratified sampling design, over-sampling from electoral wards with higher levels of ethnic diversity and socioeconomic deprivation in the 1991 UK Census [37]. Sampling and response weights were used to account for both sampling design and attrition in all analyses.

Binary logistic regression was used to produce crude and adjusted odds ratios (ORs) for the association between LLSI and dichotomised K6 score, and between LLSI and receiving treatment for depression or serious anxiety. Two-sided statistical tests using a p-value threshold of <0.05 were used throughout. All covariates listed above were included in adjusted models for both outcomes, using multiple logistic regression, which were compared with unadjusted ORs from models using simple binary logistic regression. Additionally, a sensitivity analysis for the model used for the primary outcome of K6 score was also conducted using multiple imputation using chained equations (MICE) to impute missing data for all variables included in the logistic regression model investigating the relationship between LLSI and K6 score (see Fig 1 for numbers of missing values). All variables used in the analysis model for the primary outcome were included in the imputation model. The Stata command ‘mi impute chained’ was used to impute 20 datasets. This was used to assess how the use of complete-case analyses influenced model estimates. All analyses were conducted in Stata Version 17.

Results

Of the 19,482 cohort members in end-user license agreement dataset, 7,866 cohort members provide complete exposure, outcome, and covariate data, representing 40.4% of the original sample (Fig 2).

Fig 2. Attrition diagram showing those included in complete-case analyses.

Fig 2

Unweighted cohort member characteristics for the complete-case dataset are presented in Table 1; weighted figures are available in Appendix S1 in S1 File. 15.8% of cohort members scored above the threshold for serious distress on the K6, with 21.9% of participants who reported LLSI before age 17 years scoring above the cutoff, compared with 14.5% in the unexposed group. Greater proportional differences were seen in receiving treatment for depression or serious anxiety; 9.7% in those with reported LLSI, compared to 3.5% in those without. Males had higher prevalence of LLSI, with 53.6% of those reporting an LLSI being male. Those with a reported LLSI also saw slightly higher prevalence of LLSI in proportions of those from single-parent families, those below the 60% median equivalised household income threshold, and those from the White ethnic group, although the study population is also overwhelmingly white at 88.1%.

Table 1. Unweighted summary statistics of covariates by LLSI status in complete case dataset.

Variable No LLSI (%) LLSI (%) Total
(%)
Categorical variables
Sex
 Female 3,369 (51.9) 640 (46.4) 4,009 (51.0)
 Male 3,119 (48.1) 738 (53.6) 3,857 (49.0)
Ethnic group
 White 5,696 (87.8) 1,227 (89.0) 6,923 (88.0)
 Indian 135 (2.1) 28 (2.0) 163 (2.0)
 Pakistani and Bangladeshi 267 (4.1) 50 (3.6) 317 (4.0)
 Black or Black British 159 (2.5) 29 (2.1) 188 (2.4)
 Mixed or Other Ethnic group 231 (3.6) 44 (3.2) 275 (3.5)
Family structure
 Two parents/carers 5,769 (88.9) 1,160 (84.2) 6,929 (88.1)
 Single parent/carer 719 (11.1) 218 (15.8) 937 (11.9)
Parental education
 None or overseas qualification 642 (9.9) 157 (11.4) 799 (10.2)
 NVQ level 1 459 (7.1) 114 (8.3) 573 (7.3)
 NVQ level 2 1,825 (28.1) 417 (30.3) 2,242 (28.5)
 NVQ level 3 990 (15.3) 212 (15.4) 1,202 (15.3)
 NVQ level 4 2,258 (34.8) 423 (30.7) 2,681 (34.1)
 NVQ level 5 314 (4.8) 55 (4.0) 369 (4.7)
Parental limiting longstanding illness
 No 5,217 (80.4) 967 (70.2) 6,184 (78.6)
 Yes 1,271 (19.6) 411 (29.8) 1,682 (21.4)
OECD equivalised income
 Above 60% median 4,879 (75.2) 909 (66.0) 5,788 (73.6)
 Below 60% median 1,609 (24.8) 469 (34.0) 2,078 (26.4)
Continuous variables No LLSI
mean (SD)
LLSI
mean (SD)
Total
mean (SD)
Parental Kessler-6 score 2.96 (3.40) 3.93 (4.20) 3.13 (3.57)

LLSI and serious psychological distress

21.9% (302) of those with an LLSI scored above the threshold for serious psychological distress on the Kessler-6 compared with 14.5% (938) of those without an LLSI. The crude OR for serious psychological distress at age 17 years in those with LLSI compared to those without was 1.53 (95%CI 1.29–1.83). The weighted adjusted OR was also 1.53 (95%CI 1.27–1.86, Table 2). Unweighted complete-case analyses can be seen in Appendix S2 in S1 File. Models using MICE to account for missing data retained 19,229 cohort members and produced an adjusted OR of 1.58 (95%CI 1.36–1.84), which was similar to the estimates from complete-case analyses (Appendix S3 in S1 File).

Table 2. Weighted complete-case multiple logistic regression of dichotomised Kessler-6 score.

Covariate
Weighted adjusted OR 95% CI P-value
Limiting longstanding illness
 No limiting longstanding illness 1.00 (ref)
 Limiting longstanding illness 1.53 1.27-1.86 <0.001
Sex
 Female 1.00
 Male 0.37 0.31-0.45 <0.001
Ethnic group
 White 1.00 (ref)
 Indian 0.43 0.22-0.84 0.013
 Pakistani/ Bangladeshi 0.59 0.37-0.94 0.025
 Black/ Black British 1.07 0.51-2.24 0.854
 Mixed/ Other 0.89 0.52-1.52 0.670
Family structure
 Dual parents/carers 1.00 (ref)
 Single parent/carer 1.10 0.61-1.49 0.561
Parental education
 None or overseas only 1.00 (ref)
 NVQ level 1 1.02 0.61-1.70 0.942
 NVQ level 2 0.99 0.71-1.40 0.968
 NVQ level 3 1.00 0.69-1.47 0.983
 NVQ level 4 0.94 0.66-1.33 0.733
 NVQ level 5 0.94 0.60-1.34 0.779
OECD equivalised income
 Above 60% median 1.00 (ref)
 Below 60% median 1.17 0.97-1.41 0.108
Parental limiting longstanding illness
 No 1.00 (ref)
 Yes 1.08 0.89-1.30 0.423
Parental Kessler-6 score 1.04 1.02-1.07 <0.001
Constant 0.22 0.15-0.31 <0.001

Cutoff Kessler-6 score of ≥13 used to indicate serious psychological distress

LLSI and treatment for depression or serious anxiety

9.7% (134) of those with an LLSI reported currently receiving treatment for depression or serious anxiety, compared with just 3.5% (225) in those without an LLSI. The crude OR for children and adolescents who reported currently receiving treatment for depression or serious anxiety by age 17 years in those with an LLSI compared to those without was 3.18 (95%CI 2.40–4.22), and the adjusted value was 3.02 (95%CI 2.24–4.07, Table 3). Unweighted complete-case analyses can be seen in Appendix S4 in S1 File.

Table 3. Weighted complete-case logistic regression of currently receiving treatment for depression or serious anxiety.

Covariate
Weighted adjusted OR 95% CI P-value
Limiting longstanding illness
 No limiting longstanding illness 1.00 (ref)
 Limiting longstanding illness 3.02 2.24-4.07 <0.001
Sex
 Female 1.00
 Male 0.29 0.21-0.39 <0.001
Ethnic group
 White 1.00 (ref)
 Indian 0.67 0.16-2.71 0.572
 Pakistani/ Bangladeshi 0.32 0.12-0.86 0.025
 Black/ Black British 0.48 0.14-1.64 0.241
 Mixed/ Other 0.22 0.07-0.70 0.010
Family structure
 Dual parents/carers 1.00 (ref)
 Single parent/carer 0.79 0.46-1.36 0.398
Parental education
 None or overseas only 1.00 (ref)
 NVQ level 1 1.28 0.69-2.38 0.435
 NVQ level 2 0.80 0.47-1.33 0.384
 NVQ level 3 0.61 0.35-1.08 0.087
 NVQ level 4 0.71 0.43-1.17 0.173
 NVQ level 5 0.97 0.49-1.90 0.921
OECD equivalised income
 Above 60% median 1.00 (ref)
 Below 60% median 1.09 0.76-1.55 0.646
Parental limiting longstanding illness
 No 1.00 (ref)
 Yes 1.35 0.98-1.86 0.069
Parental Kessler-6 score 1.06 1.02-1.09 0.003
Constant 0.06 0.04-0.09 <0.001

Discussion

This was the first UK-wide longitudinal study investigating the relationship between LLSI and psychological distress. This study found that children and adolescents with a known history of LLSI had an odds of 1.53 having serious psychological distress at age 17, when compared with those without an LLSI. Those with a known history of LLSI had an odds of 3.02 for reporting currently receiving treatment for depression or serious anxiety by a healthcare professional at age 17 years, when compared with those without an LLSI.

The weighted prevalence of LLSI in this study of 15.7% (Appendix S1 in S1 File) is greater than that seen in national survey data for children aged 0–15 years in a comparable time period such as The Health Survey for England at 8% [38]. The use of a longitudinal measure of LLSI in this study, which placed those with any history of self-reporting an LLSI in the exposure group may be responsible for some of this difference. Varying age ranges, areas, and definitions of LLSI across studies also make between-studies comparison of LLSI prevalence difficult, with other England surveys showing higher rates at 23% [39].

All LLSI data were taken before both outcome measurements at age 17 years. Those who reported having an LLSI at age 11–14 years, but self-categorised this as only having a mental health condition with no other type of LLSI were excluded from the exposure group for the purposes of this study. However, some participants were missing data at these sweeps, so it is not possible to assess the mental health status of some participants between the ages of 11–14 years. The longitudinal design of the current study therefore does facilitate some causal interpretation to indicate that LLSI may increase the risk of serious psychological distress, and of receiving treatment for depression or serious anxiety at age 17 years. Mediation analyses and assessment of dose-response relationships, such as severity or duration of LLSI in other populations could further explore this.

This study identified a greater proportion of adolescents with recent serious nonspecific psychological distress (15.8%) than those who were undergoing treatment for depression or serious anxiety (4.6%). This could indicate underdiagnosis of depression and serious anxiety, although some cohort members could have experienced psychological distress without meeting the threshold for treatment for depression or serious anxiety. It is important for healthcare practitioners to be aware of the increased psychological distress in adolescents with an LLSI. A separate pilot study implemented routine screening and an early stepped intervention pathway into a paediatric epilepsy clinic and was able to identify children with previously unidentified mental health difficulties and enable them to appropriately access care [40]. In another study, routine depression screening in adolescents with type 1 diabetes mellitus at quarterly appointments in a Cincinnati Children’s Hospital was able to detect depression symptoms early and create opportunities for early intervention [41]. As the current study identified increased odds of serious psychological distress or of receiving treatment for depression or serious anxiety, it may be beneficial to screen for psychological distress and provide early interventions more broadly in adolescents with any LLSI, to facilitate early detection of mental health difficulties. Future studies could investigate the relationship between contact with health professionals and diagnosis and treatment of mental health difficulties to understand this further, and to improve access to mental health support in young people.

The OR for receiving treatment for serious depression or anxiety (3.02) was greater than when measuring serious psychological distress using the K6 (1.53). As LLSIs often require treatment or regular monitoring, adolescents with an LLSI may have increased contact with healthcare professionals when compared with their peers. This may lead to increased opportunity for healthcare professionals to identify mental health difficulties in children and young people with LLSIs. It is possible that those without LLSIs may constitute a larger proportion of those with undiagnosed mental health difficulties. Further exploration of the potential benefits of screening for psychological distress outside of those with an LLSI may also be useful for the early identification of mental health difficulties.

This study adjusted for the effects of ethnicity in all adjusted models, however, the representativeness of some ethnic minority groups in the Millennium Cohort Study is limited. Previous literature has shown that young people from ethnic minority and socioeconomically deprived backgrounds face substantial barriers to accessing quality support to manage their physical and mental health [42]. Future research could examine whether the association found here varies across different ethnic groups, to establish whether the association may be stronger for groups who have more difficulties with managing their mental health.

The increased odds of serious psychological distress in those with an LLSI in this study is comparable to odds ratios from the previously mentioned UK studies investigating associations between chronic illness and mental illness (1.6) [22] and asthma and mental illness (1.38) [21]. The consistency of results suggests that the risk of mental illness may be higher for children with any LLSI. However, the added benefit of this study was the use of a longitudinal design in a more representative UK sample, covering a broader range of LLSIs than those seen in previous studies.

Although this study has found increased odds of mental health difficulties in adolescents with an LLSI, it is important to consider the moderating and potentially neutralising effects of family support, education, and management of the physical condition itself before considering mental health interventions. Adolescence often marks the transition from parent- to self-management of LLSI, with differences in the age this occurs seen across individuals and conditions [43]. As a result of this and other developmental and environmental changes, non-adherence to treatments across illnesses including asthma [44] and diabetes [45] is particularly high in adolescents. This is concerning, as non-adherence with treatment of LLSI may exacerbate symptoms or illness progression; it is possible that this could also have adverse effects on mental health outcomes. The reverse may also be true – a systematic review identified that adolescents self-reported that poor mental health made it more difficult to adhere to treatment for physical illnesses [46]. Few studies appear to have examined the mental health implications of improving LLSI treatment adherence in adolescents. As smartphone use becomes increasingly popular, one study found that a Mobile-health app which included symptom monitoring questionnaires, medication reminders, information videos, and capacity to talk to pharmacists or peers improved treatment adherence in adolescents with a low adherence at baseline [47]. A trial found that adolescents with type 1 diabetes who had received motivational interviewing had improved glycaemic control and life satisfaction, and had reduced worry [48]. Future studies could further explore the mental health impacts of comparable interventions and alternative approaches such as coaching across other chronic conditions.

Strengths and limitations

This study has several strengths. The Millennium Cohort Study provided a large nationally representative UK sample, with a prospective study design which reduced recall bias compared to a single cross-sectional analysis, and sufficient demographic and socioeconomic information for use as confounding variables.

This study also has some limitations. The high attrition rate and use of complete case analysis in this study meant that 41% of singleton cohort members recruited to the Millennium Cohort Study were included in the complete-case analyses. This may reduce the representativeness of results and lead to attrition bias. Although sensitivity analyses using multiple imputation by chained equations to account for missingness did not lead to substantial changes in model estimates, if the missing at random assumption does not hold, then estimates using multiple imputation are also likely to be biased [49].

Prior to age 11 years, parents and carers were not asked what type of health condition cohort members were affected by. This may have lead to some cohort members with a limiting mental health condition prior and no LLSI prior to age 11 years being misclassified as having an LLSI, which may have inflated the relationship between LLSI and serious psychological distress in this study.

Conclusion

This was the first large-scale longitudinal study to investigate the relationship between LLSI and psychological distress in a representative sample of UK adolescents. This study found that children and adolescents with a known LLSI are at an increased risk of serious psychological distress and of currently receiving treatment for depression or serious anxiety at age 17 years when compared with those without an LLSI. Working alongside young people to provide support, improve treatment adherence, and routinely screen for and identify psychological distress in young people with any LLSI may be beneficial.

Supporting information

S1 File. Supplementary appendices.

Supplementary appendices containing (S1) Weighted summary statistics of covariates by LLSI status in complete case dataset; (S2) Unweighted complete-case multiple logistic regression for dichotomised Kessler-6 score; (S3) Weighted multiple logistic regression of dichotomised Kessler-6 score using Multiple Imputation by Chained Equations; (S4) Unweighted complete-case multiple logistic regression of currently receiving treatment for depression or serious anxiety.

(DOCX)

pone.0306677.s001.docx (35.7KB, docx)

Data Availability

All relevant data for this study are publicly available from the UK Data Service repository (http://doi.org/10.5255/UKDA-Series-2000031).

Funding Statement

G.P. is funded by a National Institute for Health and Care Research (NIHR) Pre-doctoral Fellowship (Ref: NIHR303343). This study has received funding from the National Lottery Community Fund (previously the Big Lottery Fund) as part of the A Better Start programme (Ref 10094849) and support from the NIHR Yorkshire and Humber Applied Research Collaboration (ARC-YH; Ref: NIHR200166, see https://www.arc-yh.nihr.ac.uk). L.F. is funded by a National Institute for Health and Care Research (NIHR) Career Development Fellowship (award: CDF-2018-11-ST2-002). S.J. was funded by an National Institute for Health and Care Research fellowship (DRF-2018-11-ST2-013). The views expressed are those of the authors and not necessarily those of the National Institute for Health and Care Research or the Department of Health and Social Care. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation in the analysis.

References

  • 1.Newlove-Delgado T, Williams T, Robertson K, McManus S, Sadler K, Vizard T, et al. Mental health of children and young people in England. NHS Digital. 2021. https://files.digital.nhs.uk/97/B09EF8/mhcyp_2021_rep.pdf# [Google Scholar]
  • 2.Bebbington PE, McManus S. Revisiting the one in four: the prevalence of psychiatric disorder in the population of England 2000-2014. Br J Psychiatry. 2020;216(1):55–7. doi: 10.1192/bjp.2019.196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.NHS England Digital. Mental health of children and young people in England 2021 - wave 2 follow up to the 2017 survey. https://digital.nhs.uk/data-and-information/publications/statistical/mental-health-of-children-and-young-people-in-england/2021-follow-up-to-the-2017-survey
  • 4.NHS England Digital. Mental health of children and young people in England, 2023 - wave 4 follow up to the 2017 survey. NHS England Digital. 2023. https://digital.nhs.uk/data-and-information/publications/statistical/mental-health-of-children-and-young-people-in-england/2023-wave-4-follow-up [Google Scholar]
  • 5.Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602. doi: 10.1001/archpsyc.62.6.593 [DOI] [PubMed] [Google Scholar]
  • 6.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. ed. Washington, D.C.: American Psychiatric Association. 1994. [Google Scholar]
  • 7.Agnafors S, Barmark M, Sydsjö G. Mental health and academic performance: a study on selection and causation effects from childhood to early adulthood. Soc Psychiatry Psychiatr Epidemiol. 2021;56(5):857–66. doi: 10.1007/s00127-020-01934-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Meier MH, Hall W, Caspi A, Belsky DW, Cerdá M, Harrington HL, et al. Which adolescents develop persistent substance dependence in adulthood? Using population-representative longitudinal data to inform universal risk assessment. Psychol Med. 2016;46(4):877–89. doi: 10.1017/S0033291715002482 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hards E, Loades ME, Higson-Sweeney N, Shafran R, Serafimova T, Brigden A, et al. Loneliness and mental health in children and adolescents with pre-existing mental health problems: A rapid systematic review. Br J Clin Psychol. 2022;61(2):313–34. doi: 10.1111/bjc.12331 [DOI] [PubMed] [Google Scholar]
  • 10.Manor I, Gutnik I, Ben-Dor DH, Apter A, Sever J, Tyano S, et al. Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents - a pilot study. Eur Psychiatry. 2010;25(3):146–50. doi: 10.1016/j.eurpsy.2009.06.001 [DOI] [PubMed] [Google Scholar]
  • 11.Department of Health. Long term conditions compendium of information. Leeds: Department of Health. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/216528/dh_134486.pdf [Google Scholar]
  • 12.Office for National Statistics. Child and infant mortality in England and Wales. Office for National Statistics. 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/childhoodinfantandperinatalmortalityinenglandandwales/2021#trends-in-child-and-infant-mortality [Google Scholar]
  • 13.Anderson E, Durstine JL. Physical activity, exercise, and chronic diseases: A brief review. Sports Med Health Sci. 2019;1(1):3–10. doi: 10.1016/j.smhs.2019.08.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Allen T, Reda S, Martin S, Long P, Franklin A, Bedoya SZ, et al. The Needs of Adolescents and Young Adults with Chronic Illness: Results of a Quality Improvement Survey. Children (Basel). 2022;9(4):500. doi: 10.3390/children9040500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Delamater AM, Guzman A, Aparicio K. Mental health issues in children and adolescents with chronic illness. IJHRH. 2017;10(3):163–73. doi: 10.1108/ijhrh-05-2017-0020 [DOI] [Google Scholar]
  • 16.Ferro MA, Gorter JW, Boyle MH. Trajectories of depressive symptoms during the transition to young adulthood: the role of chronic illness. J Affect Disord. 2015;174:594–601. doi: 10.1016/j.jad.2014.12.014 [DOI] [PubMed] [Google Scholar]
  • 17.Speechley KN, Ferro MA, Camfield CS, Huang W, Levin SD, Smith ML, et al. Quality of life in children with new-onset epilepsy: a 2-year prospective cohort study. Neurology. 2012;79(15):1548–55. doi: 10.1212/WNL.0b013e31826e25aa [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zheng K, Abraham C, Bruzzese J-M, Smaldone A. Longitudinal Relationships Between Depression and Chronic Illness in Adolescents: An Integrative Review. J Pediatr Health Care. 2020;34(4):333–45. doi: 10.1016/j.pedhc.2020.01.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cobham VE, Hickling A, Kimball H, Thomas HJ, Scott JG, Middeldorp CM. Systematic Review: Anxiety in Children and Adolescents With Chronic Medical Conditions. J Am Acad Child Adolesc Psychiatry. 2020;59(5):595–618. doi: 10.1016/j.jaac.2019.10.010 [DOI] [PubMed] [Google Scholar]
  • 20.Brady AM, Deighton J, Stansfeld S. Psychiatric outcomes associated with chronic illness in adolescence: A systematic review. J Adolesc. 2017;59:112–23. doi: 10.1016/j.adolescence.2017.05.014 [DOI] [PubMed] [Google Scholar]
  • 21.Calam R, Gregg L, Goodman R. Psychological adjustment and asthma in children and adolescents: the UK Nationwide Mental Health Survey. Psychosom Med. 2005;67(1):105–10. doi: 10.1097/01.psy.0000151490.77622.37 [DOI] [PubMed] [Google Scholar]
  • 22.Brady AM, Deighton J, Stansfeld S. Chronic illness in childhood and early adolescence: A longitudinal exploration of co-occurring mental illness. Dev Psychopathol. 2021;33(3):885–98. doi: 10.1017/S0954579420000206 [DOI] [PubMed] [Google Scholar]
  • 23.Mersha AG, Tollosa DN, Bagade T, Eftekhari P. A bidirectional relationship between diabetes mellitus and anxiety: A systematic review and meta-analysis. J Psychosom Res. 2022;162:110991. doi: 10.1016/j.jpsychores.2022.110991 [DOI] [PubMed] [Google Scholar]
  • 24.Grassi L, Riba M. Cancer and severe mental illness: Bi-directional problems and potential solutions. Psychooncology. 2020;29(10):1445–51. doi: 10.1002/pon.5534 [DOI] [PubMed] [Google Scholar]
  • 25.Centre for Longitudinal Studies. Millennium Cohort Study User Guide: Surveys 1–5, 9th edn. London: Centre for Longitudinal Studies; http://doc.ukdataservice.ac.uk/doc/5795/mrdoc/pdf/mcs1-5_user_guide_ed9_2020-08-07.pdf [Google Scholar]
  • 26.Hope S, Deighton J, Micali N, Law C. Maternal mental health and childhood injury: evidence from the UK Millennium Cohort Study. Arch Dis Child. 2019;104(3):268–74. doi: 10.1136/archdischild-2017-313809 [DOI] [PubMed] [Google Scholar]
  • 27.Rosenberg AR, Bradford MC, McCauley E, Curtis JR, Wolfe J, Baker KS, et al. Promoting resilience in adolescents and young adults with cancer: Results from the PRISM randomized controlled trial. Cancer. 2018;124(19):3909–17. doi: 10.1002/cncr.31666 [DOI] [PubMed] [Google Scholar]
  • 28.Peiper N, Clayton R, Wilson R, Illback R. The performance of the K6 Scale in a large school sample. Psychol Assess. 2015;27(1):228–38. doi: 10.1037/pas0000025 [DOI] [PubMed] [Google Scholar]
  • 29.Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184–9. doi: 10.1001/archpsyc.60.2.184 [DOI] [PubMed] [Google Scholar]
  • 30.Hajebi A, Motevalian A, Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hoseini L, et al. Adaptation and validation of short scales for assessment of psychological distress in Iran: The Persian K10 and K6. Int J Methods Psychiatr Res. 2018;27(3):e1726. doi: 10.1002/mpr.1726 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Easton SD, Safadi NS, Wang Y, Hasson RG 3rd. The Kessler psychological distress scale: translation and validation of an Arabic version. Health Qual Life Outcomes. 2017;15(1):215. doi: 10.1186/s12955-017-0783-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sakurai K, Nishi A, Kondo K, Yanagida K, Kawakami N. Screening performance of K6/K10 and other screening instruments for mood and anxiety disorders in Japan. Psychiatry Clin Neurosci. 2011;65(5):434–41. doi: 10.1111/j.1440-1819.2011.02236.x [DOI] [PubMed] [Google Scholar]
  • 33.Yang M, Carson C, Creswell C, Violato M. Child mental health and income gradient from early childhood to adolescence: Evidence from the UK. SSM Popul Health. 2023;24:101534. doi: 10.1016/j.ssmph.2023.101534 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Straatmann VS, Lai E, Lange T, Campbell MC, Wickham S, Andersen A-MN, et al. How do early-life factors explain social inequalities in adolescent mental health? Findings from the UK Millennium Cohort Study. J Epidemiol Community Health. 2019;73(11):1049–60. doi: 10.1136/jech-2019-212367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Patalay P, Fitzsimons E. Development and predictors of mental ill-health and wellbeing from childhood to adolescence. Soc Psychiatry Psychiatr Epidemiol. 2018;53(12):1311–23. doi: 10.1007/s00127-018-1604-0 [DOI] [PubMed] [Google Scholar]
  • 36.Ferro MA, Boyle MH. The impact of chronic physical illness, maternal depressive symptoms, family functioning, and self-esteem on symptoms of anxiety and depression in children. J Abnorm Child Psychol. 2015;43(1):177–87. doi: 10.1007/s10802-014-9893-6 [DOI] [PubMed] [Google Scholar]
  • 37.Plewis I. Technical Report on Sampling 4th Edition. London: Centre for Longitudinal Studies. [Google Scholar]
  • 38.NHS Digital. Health Survey for England, 2019: Data Tables. NHS Digital. 2020. https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2019/health-survey-for-england-2019-data-tables [Google Scholar]
  • 39.Brooks F, Klemera E, Chester K, Magnusson J, Spencer N. Health behaviour in school aged children. Hertfordshire: Centre for Research in Public Health and Community Care. http://hbscengland.org/wp-content/uploads/2020/01/HBSC-England-National-Report-2020.pdf [Google Scholar]
  • 40.George C, Felix SA, McLellan A, Shetty J, Middleton J, Chin RF, et al. Pilot project of psychological services integrated into a pediatric epilepsy clinic: Psychology Adding Value - Epilepsy Screening (PAVES). Epilepsy Behav. 2021;120:107968. doi: 10.1016/j.yebeh.2021.107968 [DOI] [PubMed] [Google Scholar]
  • 41.Corathers S, Mara CA, Chundi PK, Kichler JC. Depression Screening of Adolescents With Diabetes: 5-Years of Implementation and Outcomes. J Am Acad Child Adolesc Psychiatry. 2019;58(6):628–32. doi: 10.1016/j.jaac.2019.01.013 [DOI] [PubMed] [Google Scholar]
  • 42.Chauhan A, Walton M, Manias E, Walpola RL, Seale H, Latanik M, et al. The safety of health care for ethnic minority patients: a systematic review. Int J Equity Health. 2020;19(1):118. doi: 10.1186/s12939-020-01223-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lerch MF, Thrane SE. Adolescents with chronic illness and the transition to self-management: A systematic review. J Adolesc. 2019;72:152–61. doi: 10.1016/j.adolescence.2019.02.010 [DOI] [PubMed] [Google Scholar]
  • 44.Morton RW, Everard ML, Elphick HE. Adherence in childhood asthma: the elephant in the room. Arch Dis Child. 2014;99(10):949–53. doi: 10.1136/archdischild-2014-306243 [DOI] [PubMed] [Google Scholar]
  • 45.Shah R, McKay SV, Levitt Katz LE, El Ghormli L, Anderson BJ, Casey TL, et al. Adherence to multiple medications in the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) cohort: effect of additional medications on adherence to primary diabetes medication. J Pediatr Endocrinol Metab. 2020;33(2):191–8. doi: 10.1515/jpem-2019-0315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hanghøj S, Boisen KA. Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review. J Adolesc Health. 2014;54(2):121–38. doi: 10.1016/j.jadohealth.2013.08.009 [DOI] [PubMed] [Google Scholar]
  • 47.Kosse RC, Bouvy ML, Belitser SV, de Vries TW, van der Wal PS, Koster ES. Effective Engagement of Adolescent Asthma Patients With Mobile Health-Supporting Medication Adherence. JMIR Mhealth Uhealth. 2019;7(3):e12411. doi: 10.2196/12411 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Channon SJ, Huws-Thomas MV, Rollnick S, Hood K, Cannings-John RL, Rogers C, et al. A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care. 2007;30(6):1390–5. doi: 10.2337/dc06-2260 [DOI] [PubMed] [Google Scholar]
  • 49.Mera-Gaona M, Neumann U, Vargas-Canas R, López DM. Evaluating the impact of multivariate imputation by MICE in feature selection. PLoS One. 2021;16(7):e0254720. doi: 10.1371/journal.pone.0254720 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Shivanand Kattimani

19 Feb 2025

-->PONE-D-24-25246-->-->The association between limiting longstanding illness and serious psychological distress in adolescents: A secondary analysis of the UK Millennium Cohort Study-->-->PLOS ONE

Dear Dr. Jarvis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Shivanand Kattimani

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Partly

Reviewer #2: Partly

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: No

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Dear Authors,

I appreciate the opportunity to review your manuscript, which presents an important examination of LLSI and psychological distress at age 17. I found the paper compelling, but I have a few suggestions that I believe would strengthen the clarity and flow of the manuscript.

In Line 29, the phrase “self-reported currently receiving treatment for depression or serious anxiety” felt a bit clunky and disrupted the flow of the text. I understand the intent behind capturing the self-reported aspect of treatment, but I wonder if there might be a more concise way to phrase this.

I also noticed areas where the flow could be improved by adjusting the placement of citations or statistics. For example, in Line 94, shifting the reported odds to follow "increased odds" might make the sentence easier to read. Similarly, I observed that citations are often placed at the beginning of sentences — in some cases, it might be more helpful to cite studies closer to the outcome statement, especially when referencing multiple sources. That said, I recognize that these are stylistic preferences, so please feel free to disregard if not relevant to your chosen writing style.

One area where I think the manuscript could benefit from further development is in the introduction. While you make a strong case for examining LLSI and distress, the importance of exploring whether treatment was being received is less clearly articulated. Expanding on this point would help reinforce the rationale for including treatment status as a key variable.

I also had some difficulty understanding the definition and classification of LLSI, and there seemed to be some discrepancies from the introduction to the methods section. In Line 134, the statement that participants answering "yes" to both questions were considered to have an LLSI seemed to suggest that receiving treatment might be a criterion for LLSI. This was a bit confusing, as I had understood LLSI to refer to chronic illness limiting activities, with treatment status as a separate variable so that associations could be examined. If treatment is not a criterion for LLSI, clarifying this distinction in the methods section would be helpful to avoid misinterpretation.

More broadly, I would encourage revisiting the definitions of LLSI and the measured variables to ensure readers can clearly understand how they are operationalized. As it currently reads, there’s a risk of confounding the association between chronic illness and distress if mental health diagnosis or treatment is part of the LLSI classification, which would be concerning from a validity of outcomes perspective. If this isn’t the case, tightening the definitions and explicitly outlining the variables measured would address this concern.

Overall, I think this is a valuable piece of research, and with some adjustments to definitions, structure, and flow, it will be even stronger.

Reviewer #2: Dear Editor, the manuscript is basically good.

In #4 above I selected "no" when asked about the writing standard. In fact, the authors do write well, but there are areas where they can explain their purpose more clearly. For example, they use a definition of LLSI (limiting and long-lasting illness) in different ways from the originally presented definition.

Additionally, as the data base is from a large UK study, the authors refer to UK codes that represent, as an example, various work-level advances (NVK). These are not explained, and readers outside of UK will not likely know what this refers to. So my primary concern as that the paper at times does not clearly explain some of it's intentions, and does not always explain terminologies.

The comments ask for basic changes. Overall it is a good manuscript from my perspective.

Thank you for the opportunity to review this manuscript!

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .-->

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.-->

Attachment

Submitted filename: Review PlosOne.docx

pone.0306677.s002.docx (23.5KB, docx)
Attachment

Submitted filename: FEB 18 2025 PONE-D-24-25246.pdf

pone.0306677.s003.pdf (1.5MB, pdf)
PLoS One. 2025 Sep 8;20(9):e0306677. doi: 10.1371/journal.pone.0306677.r002

Author response to Decision Letter 1


21 Jul 2025

The response to reviewers is included as a separate word document.

Attachment

Submitted filename: Response to reviewers duplicate.docx

pone.0306677.s004.docx (18.3KB, docx)

Decision Letter 1

Shivanand Kattimani

14 Aug 2025

The association between limiting longstanding illness and serious psychological distress in adolescents: A secondary analysis of the UK Millennium Cohort Study

PONE-D-24-25246R1

Dear Dr. Jarvis,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shivanand Kattimani

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: (No Response)

Reviewer #2: This topic is very interesting and important. Thanks to the authors for improving the manuscript based upon recommendations from the reviewers. The manuscript reads well and will contribute meaningful information to the scientific literature!

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .-->

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Shivanand Kattimani

PONE-D-24-25246R1

PLOS ONE

Dear Dr. Jarvis,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Shivanand Kattimani

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Supplementary appendices.

    Supplementary appendices containing (S1) Weighted summary statistics of covariates by LLSI status in complete case dataset; (S2) Unweighted complete-case multiple logistic regression for dichotomised Kessler-6 score; (S3) Weighted multiple logistic regression of dichotomised Kessler-6 score using Multiple Imputation by Chained Equations; (S4) Unweighted complete-case multiple logistic regression of currently receiving treatment for depression or serious anxiety.

    (DOCX)

    pone.0306677.s001.docx (35.7KB, docx)
    Attachment

    Submitted filename: Review PlosOne.docx

    pone.0306677.s002.docx (23.5KB, docx)
    Attachment

    Submitted filename: FEB 18 2025 PONE-D-24-25246.pdf

    pone.0306677.s003.pdf (1.5MB, pdf)
    Attachment

    Submitted filename: Response to reviewers duplicate.docx

    pone.0306677.s004.docx (18.3KB, docx)

    Data Availability Statement

    All relevant data for this study are publicly available from the UK Data Service repository (http://doi.org/10.5255/UKDA-Series-2000031).


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES